This document outlines treatment options for rectal cancer including neoadjuvant chemoradiation therapy with 5040cGy radiation plus 5FU chemotherapy followed by surgery such as low anterior resection (LAR) or abdominoperineal resection (APR) or clinical complete response monitoring without immediate surgery followed by FOLFOX chemotherapy since 2011.
This document outlines treatment options for rectal cancer including neoadjuvant chemoradiation therapy with 5040cGy radiation plus 5FU chemotherapy followed by surgery such as low anterior resection (LAR) or abdominoperineal resection (APR) or clinical complete response monitoring without immediate surgery followed by FOLFOX chemotherapy since 2011.
This document outlines treatment options for rectal cancer including neoadjuvant chemoradiation therapy with 5040cGy radiation plus 5FU chemotherapy followed by surgery such as low anterior resection (LAR) or abdominoperineal resection (APR) or clinical complete response monitoring without immediate surgery followed by FOLFOX chemotherapy since 2011.